Pfizer Valneva Late Stage Clinical Trials Lyme Disease Vaccine - Pymnts News
Shares in valneva rose after the french biotech company reported positive final data from a mid-stage study of a lyme disease vaccine candidate it is developing with pfizer. Pfizer and valneva entered into a collaboration agreement in april 2020 for the development and commercialization of vla15 by pfizer. There are currently no approved human vaccines for.
๐ Related Articles You Might Like:
Super Bowl 2023 Sheryl Lee Ralph Performs Lift Every Voice And Sing Christina Ricci Reveals Production On Yellowjackets Season 2 Has Wrapped Parkland Mass Shooting Remembering Lives Lost One Year Later๐ธ Image Gallery
๐ Continue Reading:
Michael B Jordan Shirtless Photos Sexiest Man Alive 2020 Super Bowl 2023 Commercials